PGWM
MYGN icon

Parisi Gray Wealth Management’s Myriad Genetics MYGN Stock Holding History

Parisi Gray Wealth Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,340
Closed -$133K – 388
2021
Q2 		$133K Buy
+4,340
New +$125K 0.05% 162

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Parisi Gray Wealth Management's MYGN Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of Myriad Genetics (MYGN) in Q3 2021, closing a stake of 4,340 shares — an estimated $133K sold.

Parisi Gray Wealth Management first reported a position in MYGN in Q2 2021 and held it in 1 quarter. The position peaked at $133K in Q2 2021. 213 funds tracked by Wall St. Rank hold MYGN as of Q3 2021.

  • Parisi Gray Wealth Management reported no remaining Myriad Genetics position as of Q3 2021 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 4,340 Myriad Genetics shares in Q3 2021, an estimated $133K.
  • Parisi Gray Wealth Management first reported a position in Myriad Genetics in Q2 2021 and held it in 1 quarter.
  • Parisi Gray Wealth Management's Myriad Genetics position peaked at $133K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.